In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Ans : Typically between 4 to 12 weeks, depending on your body, dosage, and form used
10.1161/CIR.0000000.000000757 108 WangB.TangX.MaoB.ZhangQ.TianF.ZhaoJ.et al (2024)
Comparative evaluation of safety and efficacy of glimepiride and sitagliptin in combination with metformin in patients with type 2 diabetes mellitus: Indian multicentric randomized trial - START study
Influence of calcium acetate or calcium citrate on intestinal aluminum absorption
Using both constitutive and acute depletion mouse models, we show that GPR146 deficiency confers resistance to diet-induced obesity and hepatic steatosis, accompanied by reduced circulating FFAs